Akouos Inc. (AKUS)
Company Description
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals.
The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach.
Its lead product candidate is AK-OTOF, a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene.
The company is also developing AK-CLRN1 for the auditory manifestations of Usher syndrome 3A, or USH3A; and AK-antiVEGF for vestibular schwannoma.
In addition, its precision genetic medicine platform addresses hearing loss related to genes needed for supporting cell function.
The company was incorporated in 2016 and is based in Boston, Massachusetts.
| Country | United States |
| IPO Date | Jun 26, 2020 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 103 |
| CEO | Emmanuel Simons |
Contact Details
Address: 645 Summer Street Boston, Massachusetts United States | |
| Website | https://www.akouos.com |
Stock Details
| Ticker Symbol | AKUS |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001722271 |
| CUSIP Number | 00973J101 |
| ISIN Number | US00973J1016 |
| Employer ID | 00-0000000 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Emmanuel Simons M.B.A., Ph.D. | Co- Founder, Pres, Chief Executive Officer & Director |
| Dr. Karoline K. Shair | Senior Vice President, Gen. Counsel, Chief Legal Officer & Corporation Sec. |
| Jennifer Anne Wellman M.S. | Chief Operating Officer |
| Sachiyo Minegishi | Chief Financial Officer, Treasurer, Assistant Sec. & Principal Accounting Officer |
| Dr. Aaron Tward M.D., Ph.D. | Chief Scientific Officer |
| Dr. Luk H. Vandenberghe M.D., Ph.D. | Founder & Member of Scientific Advisory Board |
| Dr. Michael John McKenna M.D. | Co-Founder, Chief Medical Officer & Member of Scientific Advisory Board |
| Richard Smith M.D. | Founder & Member of Scientific Advisory Board |
| Stacy Price | Chief Technical Officer |
| William F. Sewell Ph.D. | Founder & Member of Scientific Advisory Board |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 14, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Feb 10, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Jan 10, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Jan 10, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Dec 12, 2022 | 15-12G | Filing |
| Dec 02, 2022 | 4 | Filing |
| Dec 02, 2022 | 4 | Filing |
| Dec 02, 2022 | 4 | Filing |
| Dec 02, 2022 | 4 | Filing |
| Dec 02, 2022 | 4 | Filing |